WW International is launching a platform that integrates its wellness program with GLP-1 drugs. Should you buy the stock now?

Yesterday was a head-spinning day in the markets. After President Donald Trump announced out of the blue that he would be placing a 90-day pause on reciprocal tariffs for many countries—excluding ...

WW stock popped 38% on October 9 with the company revealing a new compounded semaglutide product to benefit from the current shortage of weight loss drugs in the market. The company has already ...

WW International exited bankruptcy with a cleaner balance sheet, slashing $1.15B in debt and relisting on Nasdaq, enabling renewed strategic focus. New leadership and board overhaul signal a pivot to ...

WW Clinic is a telehealth service from WW (formerly WeightWatchers) that integrates FDA-approved weight loss medication with WW behavioral coaching and diet tracking tools. GLP-1 medications are ...

WW International (WW) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to loss of $0.06 per share a year ago. These ...

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and ...